Top 10 Best Drug Discovery Software of 2026

Scilligence is designed for virtual screening and lead discovery work where compound selection starts with chemical structure search and iterative enrichment. It includes mechanisms for building curated compound collections, running search and filter steps, and exporting selected sets for downstream chemistry and biology activities. The system also records screening-to-assay connections so teams can trace which structures and metadata produced a given shortlist. Administrative controls and governance hooks support shared projects where multiple functions contribute curation and review.

A tradeoff appears in workflow depth versus modeling breadth because Scilligence focuses on organizing discovery, screening preparation, and decision-ready compound handling rather than replacing specialized docking engines. The best fit is when researchers need consistent compound curation and reproducible selection logic across multiple targets, campaigns, and assay sources. A common usage situation involves setting up a repeatable selection workflow for each target, then automating exports and annotations used by lab-ready design and screening teams.

Schrödinger is a drug discovery software suite that links computational chemistry engines with workflow execution for small-molecule design and optimization. The core capabilities cover molecular docking, pharmacophore modeling, and property-driven lead optimization with structure-based and ligand-based screening workflows.

Schrödinger also supports scientific workflow orchestration across simulation and modeling steps while handling common chemical structure inputs used in discovery. Integration depth centers on running and coordinating its compute-centric toolchain inside an environment that can be scripted and automated through its interface surface.

MolSoft ICM-Pro groups ligand preparation, structure alignment, docking, and result analysis around a shared internal model, which reduces format switching during iterative lead optimization cycles. Interactive 3D modeling and pose inspection connect directly to batch docking and scoring workflows, which helps teams move from hypotheses to ranked poses without exporting to multiple tools. It supports chemical structure search behaviors like similarity and substructure targeting to drive candidate triage before modeling runs.

A key tradeoff is that API and automation depth is less aligned to modern LIMS and cloud orchestration patterns than toolchains built around broader enterprise integration layers. It fits best when a team runs repeated structure modeling jobs on local compute and needs consistent curation of ligands, proteins, and docking settings across many iterations. For teams that require governance features like RBAC and audit logs for cross-team sharing, additional systems and operational controls may be needed outside the desktop workflow.

Benchling is built around a curated electronic lab notebook workflow that links sample, protocols, and results into a traceable chain of custody. It supports compound library management and assay data capture with configurable forms and structured fields for downstream analysis.

Dotmatics centers on chemical and assay data objects that connect to downstream analysis, including structure-based screening workflows and lead optimization reporting. The system supports chemical structure search with substructure and similarity modes, and it keeps results tied back to the originating libraries and experiments. Automation is driven through workflow configuration so teams can standardize curation steps, analysis steps, and review views across projects.

Aqemia is drug discovery software for teams that need chemistry and biology workflows coordinated inside a single operational environment. Its core capabilities focus on compound-centric data handling, target and assay context management, and workflow automation that connects screening outputs to downstream analysis. Aqemia also supports integration needs through an API-oriented approach for programmatic data movement and system-to-system workflows.

NVIDIA BioNeMo is positioned for end-to-end scientific computing in drug discovery by focusing on model training and inference workflows that run on NVIDIA GPU infrastructure. Core capabilities include workflow orchestration for cheminformatics and bioinformatics tasks, plus support for deep learning model development pipelines that can incorporate protein, structure, and compound representations.

BIOVIA Discovery Studio runs structure- and ligand-informed workflows that combine receptor interaction analysis, molecular docking, and visualization in one environment. It also supports pharmacophore modeling, property and toxicity prediction, and cheminformatics searches across chemical structures and assay-linked datasets.

OpenEye Orion connects OpenEye cheminformatics engines to project workflows for tasks like chemical structure search, similarity and substructure matching, and filtering large compound sets. It also supports scientific file handling for common molecular formats and integrates with upstream and downstream discovery tooling to keep molecules, annotations, and results aligned across steps.

Certara D360 is a drug discovery data and workflow environment focused on managing chemical and biological information tied to project execution. It combines structure-aware search and assay-linked record keeping with configurable work processes that track experiments from design inputs through outcomes.